LGND - Ligand Pharmaceuticals Incorporated Qarzning balans kapitallashuviga nisbati

Ligand Pharmaceuticals Incorporated (LGND) grafik logotipi

Ligand Pharmaceuticals (LGND) daromadlari patentlangan Captisol tizimlari uchun foydalanish huquqlarini sotishga va yirik hamkorlardan tushadigan to'lovlarga tayanadi, bu esa narxlar dinamikasining vizual ko'rinishi bilan tasdiqlanadi, u yerda ko'rsatkich 1.09 darajasida turibdi. Kompaniya dori vositalarini eritish bo'yicha muhim yechimlarni yaratuvchi, yetarlicha baholanmagan sanoat yetakchisi sifatida qadrlanadi. Investorlar ushbu biznesni royalti yig'ishga bo'lgan pragmatik yondashuvi va shaxsiy tadqiqotlarga minimal xarajatlar sarflayotgani uchun tanlashmoqda.

LGND (Ligand Corp) Qarzning balans qiymatiga nisbati tarixi 04.07.2022dan 29.10.2026gacha

Ligand Pharmaceuticals Incorporated (LGND) - koʻrsatkichlar kesimi va moliyaviy hisobotlar

- narx va narxlar bo'yicha konsensus prognoz:
Aksiya narxi Ligand Pharmaceuticals|LGND - Tahlilchilar konsensus prognozi
- bozor kapitallashuvi bo'yicha ma'lumotlar:
Bozor qiymati Ligand Corp|LGND - Qarz va naqd pullar hisobga olingan qiymat
- balans kapitallashuvi bo'yicha ma'lumotlar:
Bitta aksiya uchun sof aktivlar Ligand|LGND - Kompaniyaning sof aktivlari|Bozor kapitallashuvining balans qiymatiga nisbati ligand.com|LGND - Kompaniyaning umumiy aktivlari
- qarz va likvidlik bo'yicha ma'lumotlar:
Umumiy qarzning xususiy kapitalga nisbati Ligand Pharmaceuticals|LGND - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Qisqa muddatli qarzning o'z kapitaliga nisbati Ligand Pharma|LGND - Kompaniyaning umumiy yig'indi qarzi|Qarzning balans qiymatiga nisbati Ligand Corp|LGND - Uzoq muddatli majburiyatlar miqdori|Kompaniyaning qisqa muddatli qarzlari Ligand
Kompaniyaning barcha koʻrsatkichlari tahlili:LGND Ligand Pharmaceuticals
Ligand Pharma asosiy tovari

Ligand Pharmaceuticals (LGND) kompaniyasining barqaror litsenziyalash modeli, joriy qarzning kitob qiymatiga nisbati bilan birgalikda, biznesning makroiqtisodiy zarbalarga yuqori chidamliligini namoyish etadi. Jami majburiyatlarning kapitalga nisbati kredit leveraj darajasini belgilaydi, bunda koeffitsiyentning kamayishi to'lov qobiliyatini mustahkamlaydi, past geopolitik xavf sharoitidagi me'yordagi qarz esa moliyaviy resurslarni boshqarish samaradorligini tasdiqlaydi.

Ligand Pharmaceuticals raqobatchilari

Balans kapitallashuviga qarzlar HLN (Haleon plc)|kenvue.com - Balans kapitallashuviga qarzlar|Qarzning balans kapitallashuviga nisbati Verona Pharma (VRNA)|MENS: Qarzning sof aktivlarga nisbati|AMRX (Amneal Pharmaceuticals Inc) - Qarzning balans kapitallashuviga nisbati|Perrigo Corp (PRGO) - Qarzning balans qiymatiga nisbati|ALVO (Alvotech) - Balans kapitallashuviga qarzlar|Balans kapitallashuviga qarzlar liquidia.com (LQDA)|Galapagos (GLPG) - Qarzning balans qiymatiga nisbati|Qarzning sof aktivlarga nisbati ANIP (ANI Pharmaceuticals Inc)|MNKD: Qarzning balans kapitallashuviga nisbati|AMPH - Balans qiymatiga qarzlar|Qarzning balans qiymatiga nisbati Pacira BioSciences PCRX|SPRY - Qarzning balans kapitaliga nisbati|Balans kapitallashuviga qarzlar Theravance Biopharma, Inc. TBPH|Aquestive Therapeutics Inc (AQST) - Qarzning sof aktivlarga nisbati|Balans kapitallashuviga qarzlar SCPH (scPharmaceuticals, Inc.)|Balans qiymatiga qarzlar TECX|Tonix Pharmaceuticals (TNXP) - Qarzning balans kapitallashuviga nisbati|Qarzning sof aktivlarga nisbati SXTC (sxtchina.com)|Qarzning balans kapitallashuviga nisbati Eupraxia Pharmaceuticals Inc. EPRX|Qarzning balans kapitallashuviga nisbati BioHarvest Sciences, Inc. BHST|Balans kapitallashuviga qarzlar EXOZ (Invizyne Technologies, Inc.)|ORMP - Sof aktivlarga qarzlar|Balans kapitallashuviga qarzlar ENTX (enterabio.com)|ipatherapeutics.com (HYFT) - Qarzning sof aktivlarga nisbati|ABVC (ABVC BioPharma, Inc.) - Balans kapitallashuviga qarzlar|Balans kapitallashuviga qarzlar CPIX|Qarzning balans kapitallashuviga nisbati Quantum BioPharma Limited QNTM|Qarzning balans qiymatiga nisbati FibroGen Corporation (FGEN)|TELO - Balans kapitallashuviga qarzlar|RANI - Qarzning balans qiymatiga nisbati|Qarzning balans qiymatiga nisbati Synergy CHC Corporation (SNYR)|RLYB: Qarzning sof aktivlarga nisbati|Qarzning balans kapitallashuviga nisbati lexariabioscience.com (LEXX)|Pulmatrix Corporation (PULM) - Qarzlarning balans kapitallashuviga nisbati|PTHL - Balans kapitallashuviga qarzlar|Qarzning sof aktivlarga nisbati Aptorum|Balans kapitallashuviga qarzlar LYRA|Balans kapitallashuviga qarzlar IBO (Impact BioMedical, Inc.)|Qarzning balans kapitallashuviga nisbati TNF Pharmaceuticals, Inc.|cbdMD Inc. - Qarzning sof aktivlarga nisbati|PRFX: Qarzning balans kapitallashuviga nisbati|CYTO - Qarzning balans qiymatiga nisbati|LIPO: Balans kapitallashuviga qarzlar|OptiNose Inc (OPTN) - Balans kapitallashuviga qarzlar|Balans kapitallashuviga qarzlar PIRS|Qarzning balans qiymatiga nisbati Procaps Group Corp|Petros Pharmaceuticals - Balans kapitallashuviga qarzlar|Balans qiymatiga qarzlar qlsyy.net QLI|Qarzning balans qiymatiga nisbati SLRN (ACELYRIN)|TFFP - Balans kapitallashuviga qarzlar